Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in eBioMedicine.
Karim Raza, B.M.B.Ch., Ph.D., from the University of Birmingham in the United Kingdom, and colleagues examined the presence of immunesenescence in the early stages of RA development, including in patients with clinically suspected arthralgia and undifferentiated arthritis. A total of 224 participants were recruited: 69 healthy controls; 32 with clinically suspected arthralgia; 44 with undifferentiated arthritis; 23 with newly presenting disease-modifying antirheumatic drug (DMARD)-naive RA and three months or less symptom duration; and 56 with DMARD-naive RA and more than three months symptom duration.
The researchers found that patients with arthralgia or undifferentiated arthritis had reduced frequencies of naive CD4 T cells and recent thymic emigrants. Only once RA was established were other features of immunesenescence seen, including raised frequency of Th17, Tregs, and senescent-like T cells. In patients during early stages of the disease, the IMM-AGE (immuno-aging) score and other hallmarks of aging (inflammation, autophagic defects) were elevated. In patients with arthralgia, there was evidence of immunesenescence features as a predictor of RA development.
"We've discovered that immune aging isn't just a consequence of rheumatoid arthritis -- it may be a driver of the disease itself," senior author Niharika Duggal, also from the University of Birmingham, said in a statement. "We found that people in the early stages of rheumatoid arthritis, i.e. before a clinical diagnosis, show signs of faster immune system aging."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
Dementia Odds Significantly Increase With More Psychiatric Comorbidities
WEDNESDAY, Sept. 10, 2025 -- Dementia odds significantly increase with the number of psychiatric comorbidities, according to a study published online Sept. 9 in BMJ Mental...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.